Citations

Clear

4847 citation(s) found for "Tu, Eric".

Snoring as a Risk Factor for Sexual Dysfunction in Community Men
Hanak, Viktor, Jacobson, Debra J., McGree, Michaela E. , Sauver, Jennifer L. St. , Lieber, Michael M., Olson, Eric J. , Gades, Naomi M. , Jacobsen, Steven J. , Somers, Virend K. , St Sauver, Jennifer L

Mayo Clinic

The Journal of Sexual Medicine | March 26, 2008 | Volume: 5 | Issue: 4 | Pages: 898-908

10.1111/j.1743-6109.2007.00706.x | PMID 18086163 Get It

ABSTRACT Introduction Severe obstructive sleep apnea has been associated with sexual dysfunction; however, it is unclear whether milder forms of sleep disturbances might also be associated with sexual problems. Aim To evaluate the association between snoring and five measures of sexual dysfunction in a population-based sample of men. Methods A stratified random sample of men residing in Olmsted County, Minnesota completed a questionnaire containing questions from the Brief Male Sexual Function Inventory (BMSFI) and a sleep questionnaire. Main Outcome Measures Levels of sexual drive (libido), erectile function, ejaculatory function, sexual problem assessment, and sexual satisfaction as assessed by the BMSFI. Results Of 827 men with a regular sexual partner, subjects were divided into categories of heavy (N=95), moderate (N=573), and none/mild (N=159) snoring. Their median age was 64 years (range 51–90). The sexual satisfaction domain score was significantly lower in the heavy snoring group (P value=0.01). The odds of low sexual satisfaction was 2.3 (95% CI 1.2, 4.1) among the heavy snorers compared with the none/mild snoring group. This association remained statistically significant after adjustment for smoking, medical comorbidities, and mental health status. However, there was no significant difference in ejaculatory function, erectile function, sexual drive, and sexual problem assessment across snoring categories. Conclusions These data provide evidence of an association between snoring severity and reduced sexual satisfaction in a population of elderly community males. Snoring was not associated with biologic measures of sexual dysfunction.
ECG-Gated Cardiac CT Angiography Using 64-MDCT for Detection of Patent Foramen Ovale
Williamson, Eric E. , Kirsch, Jacobo , Araoz, Philip A. , Edmister, Whitney B., Borgeson, Daniel D., Glockner, James F., Breen, Jerome F.

Mayo Clinic

American Journal of Roentgenology | March 20, 2008 | Volume: 190 | Issue: 4 | Pages: 929-933

10.2214/ajr.07.3140 | PMID 18356439 Get It

Timing of Androgen Deprivation Therapy and its Impact on Survival After Radical Prostatectomy: A Matched Cohort Study
Siddiqui, Sameer , Boorjian, Stephen A. , Inman, Brant A. , Bagniewski, Stephanie M., Bergstralh, Eric J., Blute, Michael L., Inman, Brant A

Mayo Clinic

Journal of Urology | March 19, 2008 | Volume: 179 | Issue: 5 | Pages: 1830-1837

10.1016/j.juro.2008.01.022 | PMID 18353378 Get It

Human phenylethanolamineN-methyltransferase genetic polymorphisms and exercise-induced epinephrine release
Snyder, Eric M., Salavaggione, Oreste E., Moon, Irene, Batzler, Anthony , Yee, Vivien C., Schaid, Daniel J. , Johnson, Bruce D., Weinshilboum, Richard M. , Ji, Yuan , Fridley, Brooke L. , Joyner, Michael J. , Weinshilboum, Richard M.

Mayo Clinic

Physiological Genomics | March 19, 2008 | Volume: 33 | Issue: 3 | Pages: 323-332

10.1152/physiolgenomics.00248.2007 | PMID 18349382 Get It

Phenylethanolamine N-methyltransferase (PNMT) catalyzes the synthesis of epinephrine from norepinephrine. We previously identified and functionally characterized common sequence variation in the PNMT gene. In the present study, we set out to determine whether common PNMT genetic polymorphisms might be associated with individual variation in circulating epinephrine levels during exercise in 74 Caucasian American subjects. Circulating epinephrine levels were measured in each subject at baseline and during two different levels of exercise, ∼40% and ∼75% of peak workload. The PNMT gene was resequenced with DNA from each study subject. Eight novel PNMT polymorphisms were identified, including a C319T (Arg107Cys) nonsynonymous single nucleotide polymorphism (SNP) and I1G(280)A, a SNP located in the first intron of the gene. The I1G(280)A SNP was significantly associated with decreased exercise-induced circulating epinephrine levels and with a decreased epinephrine-to-norepinephrine ratio. The Cys107 recombinant allozyme displayed significantly lower levels of both PNMT activity and immunoreactive protein than the wild-type allozyme after transfection into COS-1 cells, but it did not appear to be associated with level of epinephrine in these subjects. Electrophoretic mobility shift and reporter gene assays performed with the I1G(280)A SNP indicated that this polymorphism could bind nuclear proteins and might modulate gene transcription. Our studies suggest that functionally significant variant sequence in the human PNMT gene might contribute to individual variation in levels of circulating epinephrine during exercise.
Identification of Prognostic Biomarkers for Prostate Cancer
Kosari, Farhad , Munz, Jan Marie A., Savci‐Heijink, C. Dilara , Spiro, Craig, Klee, Eric W. , Kube, Dagmar Marie, Tillmans, Lori S. , Karnes, R. Jeffrey , Cheville, John C. , Vasmatzis, George , Slezak, Jeff M.

Mayo Clinic

Clinical Cancer Research | March 17, 2008 | Volume: 14 | Issue: 6 | Pages: 1734-1743

10.1158/1078-0432.ccr-07-1494 | PMID 18347174 Get It

Abstract Purpose: This paper describes a process for the identification of genes that can report on the aggressiveness of prostate tumors and thereby add to the information provided by current pathologic analysis. Materials and Methods: Expression profiling data from over 100 laser capture microdissection derived samples from nonneoplastic epithelium; Gleason patterns 3, 4, and 5 and node metastasis prostate cancer were used to identify genes at abnormally high levels in only some tumors. These variably overexpressed genes were stratified by their association with aggressive phenotypes and were subsequently filtered to exclude genes with redundant expression patterns. Selected genes were validated in a case-control study in which cases (systemic progression within 5 years) and controls (no systemic progression at 7 years of follow-up) were matched for all clinical and pathologic criteria from time of prostatectomy (n = 175). Both cases and controls, therefore, could have nodal invasion or seminal vesicle involvement at the time of initial treatment. Results: A number of candidate variably overexpressed genes selected for their association with aggressive prostate cancer phenotype were evaluated in the case control study. The most prominent candidates were SSTR1 and genes related to proliferation, including TOP2A. Conclusions: The process described here identified genes that add information not available from current clinical measures and can improve the prognosis of prostate cancer.
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons
Liang, Winnie S. , Reiman, Eric M. , Valla, Jon, Dunckley, Travis , Beach, Thomas G. , Grover, Andrew, Niedzielko, Tracey L., Schneider, Lonnie , Mastroeni, Diego , Caselli, Richard J. , Kukull, Walter A. , Morris, John C. , Hulette, Christine M., Schmechel, Donald E., Rogers, Joseph, Stephan, Dietrich A. , Morris, John C

Mayo Clinic

Proceedings of the National Academy of Sciences | March 10, 2008 | Volume: 105 | Issue: 11 | Pages: 4441-4446

10.1073/pnas.0709259105 | PMID 18332434 Get It

Alzheimer's disease (AD) is associated with regional reductions in fluorodeoxyglucose positron emission tomography (FDG PET) measurements of the cerebral metabolic rate for glucose, which may begin long before the onset of histopathological or clinical features, especially in carriers of a common AD susceptibility gene. Molecular evaluation of cells from metabolically affected brain regions could provide new information about the pathogenesis of AD and new targets at which to aim disease-slowing and prevention therapies. Data from a genome-wide transcriptomic study were used to compare the expression of 80 metabolically relevant nuclear genes from laser-capture microdissected non-tangle-bearing neurons from autopsy brains of AD cases and normal controls in posterior cingulate cortex, which is metabolically affected in the earliest stages; other brain regions metabolically affected in PET studies of AD or normal aging; and visual cortex, which is relatively spared. Compared with controls, AD cases had significantly lower expression of 70% of the nuclear genes encoding subunits of the mitochondrial electron transport chain in posterior cingulate cortex, 65% of those in the middle temporal gyrus, 61% of those in hippocampal CA1, 23% of those in entorhinal cortex, 16% of those in visual cortex, and 5% of those in the superior frontal gyrus. Western blots confirmed underexpression of those complex I–V subunits assessed at the protein level. Cerebral metabolic rate for glucose abnormalities in FDG PET studies of AD may be associated with reduced neuronal expression of nuclear genes encoding subunits of the mitochondrial electron transport chain.
Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy
Boorjian, Stephen A. , Karnes, R. Jeffrey , Rangel, Laureano J. , Bergstralh, Eric J., Blute, Michael L.

Mayo Clinic

Journal of Urology | March 6, 2008 | Volume: 179 | Issue: 4 | Pages: 1354-1361

10.1016/j.juro.2007.11.061 | PMID 18289596 Get It

Radical Retropubic Prostatectomy in Immunosuppressed Transplant Recipients
Thompson, R. Houston, Leibovich, Bradley C. , Karnes, R. Jeffrey , Bergstralh, Eric J., Blute, Michael L.

Mayo Clinic

Journal of Urology | March 6, 2008 | Volume: 179 | Issue: 4 | Pages: 1349-1353

10.1016/j.juro.2007.11.054 | PMID 18289598 Get It

Stabilization of the atlantoaxial complex via C-1 lateral mass and C-2 pedicle screw fixation in a multicenter clinical experience in 102 patients: modification of the Harms and Goel techniques
Aryan, Henry E., Newman, C. Benjamin , Nottmeier, Eric W. , Acosta, Frank L. , Wang, Vincent Y., Ames, Christopher Pearson

Mayo Clinic

Journal of Neurosurgery: Spine | February 29, 2008 | Volume: 8 | Issue: 3 | Pages: 222-229

10.3171/spi/2008/8/3/222 | PMID 18312073 Get It

ObjectStabilization of the atlantoaxial complex has proven to be very challenging. Because of the high mobility of the C1–2 motion segment, fusion rates at this level have been substantially lower than those at the subaxial spine. The set of potential surgical interventions is limited by the anatomy of this region. In 2001 Jürgen Harms described a novel technique for individual fixation of the C-1 lateral mass and the C-2 pedicle by using polyaxial screws and rods. This method has been shown to confer excellent stability in biomechanical studies. Cadaveric and radiographic analyses have indicated that it is safe with respect to osseous and vascular anatomy. Clinical outcome studies and fusion rates have been limited to small case series thus far. The authors reviewed the multicenter experience with 102 patients undergoing C1–2 fusion via the polyaxial screw/rod technique. They also describe a modification to the Harms technique.MethodsOne hundred two patients (60 female and 42 male) with an average age of 62 years were included in this analysis. The average follow-up was 16.4 months. Indications for surgery were instability at the C1–2 level, and a chronic Type II odontoid fracture was the most frequent underlying cause. All patients had evidence of instability on flexion and extension studies. All underwent posterior C-1 lateral mass to C-2 pedicle or pars screw fixation, according to the method of Harms. Thirty-nine patients also underwent distraction and placement of an allograft spacer into the C1–2 joint, the authors' modification of the Harms technique. None of the patients had supplemental sublaminar wiring.ResultsAll but 2 patients with at least a 12-month follow-up had radiographic evidence of fusion or lack of motion on flexion and extension films. All patients with an allograft spacer demonstrated bridging bone across the joint space on plain x-ray films and computed tomography. The C-2 root was sacrificed bilaterally in all patients. A postoperative wound infection developed in 4 patients and was treated conservatively with antibiotics and local wound care. One patient required surgical debridement of the wound. No patient suffered a neurological injury. Unfavorable anatomy precluded the use of C-2 pedicle screws in 23 patients, and thus, they underwent placement of pars screws instead.ConclusionsFusion of C1–2 according to the Harms technique is a safe and effective treatment modality. It is suitable for a wide variety of fracture patterns, congenital abnormalities, or other causes of atlantoaxial instability. Modification of the Harms technique with distraction and placement of an allograft spacer in the joint space may restore C1–2 height and enhance radiographic detection of fusion by demonstrating a graft–bone interface on plain x-ray films, which is easier to visualize than the C1–2 joint.
Serum Biomarker Profile Associated With High Bone Turnover and BMD in Postmenopausal Women
Bhattacharyya, Sudeepa , Siegel, Eric R. , Achenbach, Sara J., Khosla, Sundeep , Suva, Larry J. , Khosla, Sundeep

Mayo Clinic

Journal of Bone and Mineral Research | February 26, 2008 | Volume: 23 | Issue: 7 | Pages: 1106-1117

10.1359/jbmr.080235 | PMID 18302502 Get It

Abstract Early diagnosis of the onset of osteoporosis is key to the delivery of effective therapy. Biochemical markers of bone turnover provide a means of evaluating skeletal dynamics that complements static measurements of BMD by DXA. Conventional clinical measurements of bone turnover, primarily the estimation of collagen and its breakdown products in the blood or urine, lack both sensitivity and specificity as a reliable diagnostic tool. As a result, improved tests are needed to augment the use of BMD measurements as the principle diagnostic modality. In this study, the serum proteome of 58 postmenopausal women with high or low/normal bone turnover (training set) was analyzed by surface enhanced laser-desorption/ionization time-of-flight mass spectrometry, and a diagnostic fingerprint was identified using a variety of statistical and machine learning tools. The diagnostic fingerprint was validated in a separate distinct test set, consisting of serum samples from an additional 59 postmenopausal women obtained from the same Mayo cohort, with a gap of 2 yr. Specific protein peaks that discriminate between postmenopausal patients with high or low/normal bone turnover were identified and validated. Multiple supervised learning approaches were able to classify the level of bone turnover in the training set with 80% sensitivity and 100% specificity. In addition, the individual protein peaks were also significantly correlated with BMD measurements in these patients. Four of the major discriminatory peaks in the diagnostic profile were identified as fragments of interalpha-trypsin-inhibitor heavy chain H4 precursor (ITIH4), a plasma kallikrein-sensitive glycoprotein that is a component of the host response system. These data suggest that these serum protein fragments are the serum-borne reflection of the increased osteoclast activity, leading to the increased bone turnover that is associated with decreasing BMD and presumably an increased risk of fracture. In conjunction with the identification of the individual proteins, this protein fingerprint may provide a novel approach to evaluate high bone turnover states.